Intermediate-Risk: Do You Need Hormone Therapy With Radiation? | #MarkScholzMD #AlexScholz #PCRI

(14:6)

Choosing a Treatment for Intermediate Risk Prostate Cancer | Prostate Cancer Staging Guide

(7:44)

Intermediate-Risk Prostate Cancer Treatment - MUSC Hollings

(23:20)

Intermediate Risk Prostate Cancer

(18:58)

Active surveillance or intervention in intermediate-risk prostate cancer

(1:42)

Diagnosis of Intermediate-Risk Polycythemia Vera

(2:47)

Victim Survivor: Intermediate Risk Assessment

(8:42)

Low Risk (Gleason 3+3=6) \u0026 Intermediate Risk (Gleason 3+4=7) Prostate Cancer Q+A | PCRI #13

(6:42)

Can a Healthy Lifestyle Beat Your Genetic Cancer Risk? Surprising findings in JNCI

(16:)

Determining How Aggressively to Treat Relapsed \u0026 Intermediate-Risk Prostate Cancer | Mark Scholz, MD

(5:54)

Intermediate Risk Prostate Cancer: Paul Nguyen, MD

(2:22)

Role of genomic profiling in the management of intermediate-risk prostate cancer

(2:57)

SBRT for the Intermediate-Risk (Teal) Prostate Cancer | Prostate Cancer Staging Guide

(5:2)

LB-100 in low and intermediate risk MDS

(1:36)

Intermediate Risk Prostate Cancer: Daniel Spratt, MD

(2:41)

When should patients with intermediate-risk AML be indicated for alloSCT?

(1:51)

Treatment of intermediate-risk AML with gemtuzumab ozogamicin

(1:55)

Focal Therapy for Men with Intermediate Risk Prostate Cancer

(18:53)

Active Surveillance in Favorable Intermediate-Risk Prostate Cancer

(11:13)

Combination Therapy for High-Risk, Hormone Therapy Duration for Intermediate-Risk | YT Comments #28

(3:54)